An amendment sponsored by Senator Bernie Sanders was one of three that addressed the issue, but they were all voted down. By Kayleigh Rogers.

federal prosecutors in Massachusetts announced the arrest of six former employees, including a former CEO and two former vice presidents, of the Phoenix-based and NASDAQ-traded fentanyl producer Insys Therapeutics… By Ben Mathis-Lilley.

Twenty states filed a lawsuit Thursday against Mylan NV, Teva Pharmaceuticals and four other generic drug makers, saying they conspired on pricing of two common generic drugs, according to a copy of the complaint. By Diane Bartz and Sarah N. Lynch.

How the 21st Century Cures Act is set to shape patients’ access to cellular therapies, for better and for worse. By Megan Molteni. (Dec. 6, 2016)

The lies and misunderstandings surrounding ADHD, from Rousseau to contemporary America. By Richard Orange.

A STAT investigation shows that Purdue Pharma paid rebates to a pharmacy benefit manager to thwart a West Virginia plan to limit prescriptions of OxyContin. By David Armstrong.

The climax of a standoff with the pharmaceutical industry over high prices. By James Hamblin.

Investigative journalist Alan Schwarz sounds the alarm. By Gareth Cook.

The company behind America’s most popular drug to treat addicts actually claimed its pills could kill kids to get a new patent and $1 billion. By Christopher Moraff.

After Bernie Sanders attacked drug companies in his speech, drug lobbyists could be seen chatting with senior party officials over charcuterie and cheese. By Dylan Scott.

Illicit OxyContin devastated the entire Everett region in Washngton. At the height of the drug’s popularity, it was a factor in more than half of the crimes in Snohomish County. By Harriet Ryan, Lisa Girion and Scott Glover.

Especially when it comes to basic things like healthcare.​ By Charles P. Pierce.

Last week, as Vermont Governor Peter Shumlin signed off on the first state law requiring drug companies to justify steep price hikes, Pfizer was in the process of raising the list prices of its drugs by an average of 8.8 percent, according to a Pfizer spokesperson. The price boost follows a similar one in January, which involved raising the list price of more than 100 drugs, some by as much as 20 percent. Pfizer isn’t alone in this trend. Drug companies including AbbVie, Eli Lilly, Merck, and Bristol-Myers Squibb...

Too many medical trials move their goalposts halfway through. A new initiative aims to change that

Soaring costs of brand name and specialty drugs outpacing inflation, income of elderly. By Beth Mole.

The World Health Organization considers it an essential medicine, which means it should be available “at a price the individual and the community can afford.” So why is this product increasingly too expensive for many Americans? In the United States, just three pharmaceutical giants hold patents that allow them to manufacture insulin: Eli Lilly, Sanofi and Novo Nordisk. By Kasia Lipska. (Feb. 20)

Robert Califf's ties to Big Pharma run deep and the Obama nominee just sailed through the U.S. Senate. By Martha Rosenberg.

The profits lie in treating later-stage cancers; a study shows it’s because of the incentives in the interplay between the patent system and the F.D.A. approval process. By Austin Frakt.

America's unique pharmaceutical pricing system, explained. By Julia Belluz. (Dec. 18)

It turns out Canada’s largest pharmaceutical company, Valeant, is not really Canadian. Now it’s getting lots of attention— for all the wrong reasons. By Bruce Livesey.